G. Carpinelli et al., DIFFERENTIATION OF GLIOBLASTOMA-MULTIFORME FROM ASTROCYTOMAS BY IN-VITRO H-1 MRS ANALYSIS OF HUMAN BRAIN-TUMORS, Anticancer research, 16(3B), 1996, pp. 1559-1563
In vitro high resolution H-1 NMR spectroscopy allows non-invasive meta
bolic evaluation of specimens derived form surgically biopsed or resec
ted brain tumors, with the aim of identifying potential markers of dif
ferent malignancy grading, and improving diagnostic and therapeutic st
rategies. In the present study we evaluated 36 patients affected by di
fferent brain gliomas (7 well differentiated astrocytomas, 7 anaplasti
c astrocytomas, 16 glioblastomas, 6 oligodendrogliomas). These analyse
s allowed discrimination between well differentiated and anaplastic as
trocytomas (ALL + AA) and glioblastoma multiforme (FM) samples on the
basis of the ratio between the integrated choline-containing resonance
(b''Cho'') and the creatine peaks (creatine (Cr) + Phosphocreatine (P
Cr)). While no definite difference was found between AII and AA, signi
ficantly higher values were observed for this ratio in GM. Other signa
ls, derived from different metabolites, auch as Glycine (Gly) and N-ac
etyl-aspartate (NAA), may also assume relevance in different tumor dia
gnosis. In this study an increased [Gly]/[Cr+PCr] ratio was observed i
n our tumor specimens may be explained on the basis of tumor cell infi
ltration into brain adjacent tissue. Interesting, but inconclusive, ar
e the data concerning oligodendrogliomas, which, also in well differen
tiated forms, exhibit increased levels of b''Cho''/(Cr+PCr) ratio. The
present study confims the role of MRS in the biochemical characteriza
tion of neoplastic brain tissue and its potential contribution to a be
tter selection of multidisciplinary treatment strategies.